Published in Nat Rev Immunol on September 01, 2012
Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol (2013) 2.19
Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides. Eur J Immunol (2014) 1.49
Concern Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy. Front Immunol (2013) 1.41
Clonotypically similar hybrid αβ T cell receptors can exhibit markedly different surface expression, antigen specificity and cross-reactivity. Clin Exp Immunol (2015) 1.40
Reassessing target antigens for adoptive T-cell therapy. Nat Biotechnol (2013) 1.34
Estimating the diversity, completeness, and cross-reactivity of the T cell repertoire. Front Immunol (2013) 1.14
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity. Nat Immunol (2015) 1.03
αβ T cell receptors as predictors of health and disease. Cell Mol Immunol (2015) 1.01
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem (2012) 0.96
The molecular determinants of CD8 co-receptor function. Immunology (2012) 0.94
T-cell receptor specificity maintained by altered thermodynamics. J Biol Chem (2013) 0.94
Approaches to vaccines against Orientia tsutsugamushi. Front Cell Infect Microbiol (2013) 0.94
Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics (2015) 0.93
T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions. J Biol Chem (2013) 0.93
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity. J Clin Invest (2016) 0.90
Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs. Immunol Rev (2014) 0.89
Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode. Front Immunol (2013) 0.88
Involvement of CD8(+) T Cells in Multiple Sclerosis. Front Immunol (2015) 0.85
Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication. J Virol (2013) 0.85
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses. J Immunol (2016) 0.85
TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst. Elife (2015) 0.84
The T cell antigen receptor: the Swiss army knife of the immune system. Clin Exp Immunol (2015) 0.82
Specific increase in potency via structure-based design of a TCR. J Immunol (2014) 0.82
CD8(+) T cell cross-reactivity profiles and HIV-1 immune escape towards an HLA-B35-restricted immunodominant Nef epitope. PLoS One (2013) 0.81
Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. J Biol Chem (2013) 0.81
Advances in T-cell epitope engineering. Front Immunol (2013) 0.80
Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes. Front Immunol (2013) 0.80
Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis. J Virol (2015) 0.79
Discovery of a protective Rickettsia prowazekii antigen recognized by CD8+ T cells, RP884, using an in vivo screening platform. PLoS One (2013) 0.79
The versatility of the αβ T-cell antigen receptor. Protein Sci (2014) 0.79
Frequency Patterns of T-Cell Exposed Amino Acid Motifs in Immunoglobulin Heavy Chain Peptides Presented by MHCs. Front Immunol (2014) 0.79
Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells. J Virol (2014) 0.79
Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation. Haematologica (2014) 0.79
Structural mechanism underpinning cross-reactivity of a CD8+ T-cell clone that recognises a peptide derived from human telomerase reverse transcriptase. J Biol Chem (2016) 0.79
Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens. Oncotarget (2016) 0.77
Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy. Sci Rep (2016) 0.77
Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide-MHC Interactions. Front Oncol (2015) 0.77
The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice. PLoS One (2015) 0.77
The growth threshold conjecture: a theoretical framework for understanding T-cell tolerance. R Soc Open Sci (2015) 0.77
How many TCR clonotypes does a body maintain? J Theor Biol (2015) 0.77
CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep (2016) 0.77
Immunogenomics: a foundation for intelligent immune design. Genome Med (2015) 0.76
Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides-As Antigens for Th Cells. Front Immunol (2015) 0.76
The ultimate mix and match: making sense of HLA alleles and peptide repertoires. Immunol Cell Biol (2015) 0.76
Immune deficiency and autoimmunity in patients with CTLA-4 mutations. Clin Exp Immunol (2017) 0.76
Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation. Front Immunol (2016) 0.75
T cells: Memories of the future. Nat Rev Immunol (2013) 0.75
Stochastic descriptors to study the fate and potential of naive T cell clonotypes in the periphery. J Math Biol (2016) 0.75
On the Role of CD8(+) T Cells in Determining Recovery Time from Influenza Virus Infection. Front Immunol (2016) 0.75
Targeting B-cell malignancies through human B-cell receptor specific CD4(+) T cells. Oncoimmunology (2016) 0.75
Single-molecule motions of MHC class II rely on bound peptides. Biophys J (2015) 0.75
The Unspecific Side of Acquired Immunity Against Infectious Disease: Causes and Consequences. Front Microbiol (2016) 0.75
Vaccination and heterologous immunity: educating the immune system. Trans R Soc Trop Med Hyg (2015) 0.75
Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets. Hum Vaccin Immunother (2016) 0.75
Immune parameters to consider when choosing T-cell receptors for therapy. Front Immunol (2013) 0.75
Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor. Sci Rep (2017) 0.75
Extensive T-Cell Epitope Repertoire Sharing among Human Proteome, Gastrointestinal Microbiome, and Pathogenic Bacteria: Implications for the Definition of Self. Front Immunol (2015) 0.75
T-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clones. J Immunol Methods (2016) 0.75
Human CD8(+) T cells transduced with an additional receptor bispecific for both Mycobacterium tuberculosis and HIV-1 recognize both epitopes. J Cell Mol Med (2016) 0.75
Antigen-specific immunotherapies in rheumatic diseases. Nat Rev Rheumatol (2017) 0.75
Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity. PLoS One (2017) 0.75
Cancer regression in patients after transfer of genetically engineered lymphocytes. Science (2006) 16.96
T-cell antigen receptor genes and T-cell recognition. Nature (1988) 16.77
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Positive and negative selection of T cells. Annu Rev Immunol (2002) 8.32
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57
Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol (2012) 7.39
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
The somatic generation of immune recognition. Eur J Immunol (1971) 6.80
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 5.82
IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res (2003) 5.64
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res (2008) 5.42
Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol (2008) 5.17
Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol (1998) 5.11
A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today (1998) 5.07
Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 5.01
THE NATURAL-SELECTION THEORY OF ANTIBODY FORMATION. Proc Natl Acad Sci U S A (1955) 4.24
Response of naïve and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol (2000) 4.08
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 3.64
Population biology of antigen presentation by MHC class I molecules. Science (1996) 3.58
How a single T cell receptor recognizes both self and foreign MHC. Cell (2007) 3.20
No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol (2002) 3.20
Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science (1998) 3.15
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest (2008) 3.11
The repertoire of T cells shaped by a single MHC/peptide ligand. Cell (1996) 3.04
Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol (2005) 2.97
Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat Immunol (2007) 2.78
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol (2001) 2.77
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med (2008) 2.64
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol (2007) 2.55
Molecular mimicry and immune-mediated diseases. FASEB J (1998) 2.53
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol (2005) 2.52
Positive Darwinian selection promotes charge profile diversity in the antigen-binding cleft of class I major-histocompatibility-complex molecules. Mol Biol Evol (1990) 2.41
The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol (1992) 2.34
A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science (1989) 2.32
Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med (2008) 2.17
CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (1995) 2.15
A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem (2011) 2.06
The shaping of T cell receptor recognition by self-tolerance. Immunity (2009) 2.06
Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial. Proc Natl Acad Sci U S A (2007) 2.03
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity (2005) 2.03
Human TCR-binding affinity is governed by MHC class restriction. J Immunol (2007) 2.02
Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem (2007) 1.95
Molecular mimicry and autoimmunity. N Engl J Med (1999) 1.95
Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem (2005) 1.92
A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers. Immunity (2011) 1.84
Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol (2011) 1.78
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78
Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology (2009) 1.78
Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest (2005) 1.76
Specificity and degeneracy of T cells. Mol Immunol (2004) 1.71
T cell receptor gene diversity and selection. Annu Rev Biochem (1990) 1.69
HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol (1998) 1.68
Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med (2005) 1.68
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci U S A (2010) 1.60
Monoclonal TCR-redirected tumor cell killing. Nat Med (2012) 1.57
Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Biochem J (2008) 1.56
T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity (2009) 1.55
A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity (2000) 1.54
Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem (2009) 1.51
CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J Immunol (1998) 1.50
Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J Immunol (2010) 1.48
Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med (1996) 1.48
The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis (2006) 1.47
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol (2012) 1.46
TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. J Immunol (2011) 1.46
Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J Exp Med (1999) 1.45
CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys J (2005) 1.38
Selection of functional T cell receptor mutants from a yeast surface-display library. Proc Natl Acad Sci U S A (1999) 1.38
Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity (2007) 1.33
Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol (1999) 1.27
T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity (1997) 1.24
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection. PLoS Pathog (2010) 1.18
Discrimination of MHC-derived odors by untrained mice is consistent with divergence in peptide-binding region residues. Proc Natl Acad Sci U S A (2002) 1.18
Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. EMBO J (2011) 1.17
Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 1.16
CD8 controls T cell cross-reactivity. J Immunol (2010) 1.15
Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J Immunol (2004) 1.12
Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat Immunol (2008) 1.11
Quantitating T cell cross-reactivity for unrelated peptide antigens. J Immunol (2009) 1.11
Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein. J Virol (2003) 1.09
Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells. J Immunol (2007) 1.06
The history of the smallpox vaccine. J Infect (2005) 1.05
Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism. J Mol Biol (2011) 1.03
Cutting edge: Evidence for a dynamically driven T cell signaling mechanism. J Immunol (2012) 1.03
Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes. J Immunol (2010) 1.00
CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol (2009) 1.00
Coreceptor CD8-driven modulation of T cell antigen receptor specificity. J Theor Biol (2007) 1.00
A uniquely high level of recombination at the HLA-B locus. Proc Natl Acad Sci U S A (1994) 0.98
Infection, mimics, and autoimmune disease. J Clin Invest (2001) 0.94
Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals. J Transl Med (2003) 0.91
Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes. Proc Natl Acad Sci U S A (2009) 0.90
Antigen arrays in T cell immunology. Curr Opin Immunol (2000) 0.86
Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases. Eur J Immunol (1999) 0.84